CenExel Welcomes Patrick McLaughlin as Chief Operating Officer
CenExel, a prominent network in clinical trials, is thrilled to announce the appointment of Patrick McLaughlin as its new Chief Operating Officer (COO). With nearly 30 years of experience in the life sciences sector, Patrick brings invaluable expertise to the CenExel executive team.
Responsibilities of the New COO
In his new position, Patrick will be responsible for the development and execution of strategic initiatives throughout CenExel’s extensive network of clinical research sites. His primary focus will be on driving growth, improving operational efficiencies, and fostering collaborations with both internal and external partners. Under his leadership, CenExel aims to continue providing innovative clinical research services while maintaining the highest standards of quality, regulatory compliance, and innovation.
Patrick McLaughlin's Career Highlights
Patrick's impactful career in clinical research began in 1996 when he became President of the Institute of Clinical Research (ICR). His leadership led to ICR's successful acquisition by Protocare, which elevated its profile in the clinical research field. In 2007, while serving as Executive Director of the Advanced Clinical Research Institute, he expanded the organization into Phase I clinical trials, rebranding it as Anaheim Clinical Trials (ACT). This facility emerged as a leading and innovative entity in the industry and was acquired by CenExel in 2019.
Leadership Team's Perspective on Patrick's Appointment
Ryan Brooks, Executive Chairman of CenExel’s Board of Directors and Chief Executive Officer, expressed his enthusiasm regarding Patrick’s appointment. He stated, "We are excited to welcome Patrick to our leadership team. His demonstrated ability to drive operational excellence and his comprehensive understanding of the clinical research landscape make him the perfect fit to guide our organization through its next growth phase. We eagerly anticipate the positive impact Patrick will have on CenExel’s ongoing success."
Patrick's Vision for CenExel
Sharing his excitement about the new role, Patrick said, "I am honored to join CenExel’s executive team as Chief Operating Officer and to collaborate with such a talented group of professionals. CenExel has an outstanding reputation in the industry, and I look forward to contributing to its mission of advancing clinical research and enhancing patient outcomes." His extensive experience is expected to play a crucial role in CenExel’s continued growth and dedication to innovation in clinical research.
About CenExel
CenExel is a nationwide network of clinical research sites committed to supporting the life sciences industry in the discovery and development of transformative therapies. They offer exceptional research support in the design and execution of complex clinical trials, utilizing scientific expertise, seasoned Principal Investigators, and integrated operational excellence.
Dedication to Quality and Innovation
With a workforce of over 1,200 employees across 18 locations in major metropolitan areas, CenExel’s Centers of Excellence have successfully conducted thousands of studies with remarkable accuracy and efficiency. Their steadfast commitment to quality, patient experience, and client success is essential for achieving successful clinical development outcomes.
Advancing Clinical Development
CenExel’s profound expertise and operational capabilities enable pharmaceutical and biotech companies to gain vital insights into diseases, thereby accelerating clinical development. Their focus is on delivering innovative treatments that enhance global patient outcomes.
Frequently Asked Questions
Who is the new COO of CenExel?
Patrick McLaughlin has been appointed as the Chief Operating Officer.
What responsibilities will Patrick have in his new role?
Patrick will oversee strategic initiatives and drive organizational growth and operational efficiency across CenExel's network.
What prior experience does Patrick bring to CenExel?
Patrick has nearly three decades of experience in the life sciences sector, including leadership roles at the Institute of Clinical Research and Advanced Clinical Research Institute.
What is CenExel known for?
CenExel is recognized for its extensive clinical trial network and commitment to high standards in clinical research and development.
How many employees does CenExel have?
CenExel employs over 1,200 people across 18 locations in major U.S. metro areas.
